Screening compound: C19H20N4O2S (E213-0377)

Screening compound: C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>S (E213-0377)
Screening compound: C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>S (E213-0377) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C19H20N4O2S (E213-0377)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E213-0377

Molecular Formula

C19H20N4O2S (C19 H20 N4 O2 S)

Compound Name

3-methyl-4-oxo-N~2~-(2-pyridylmethyl)-4,6,7,8,9,10-hexahydrothieno[2',3':4,5]pyrimido[1,2-a]azepine-2-carboxamide

IUPAC name

4-methyl-2-oxo-N-[(pyridin-2-yl)methyl]-6-thia-18-diazatricyclo[7.5.0.0^{37}]tetradeca-3(7)48-triene-5-carboxamide

SMILES

Cc1c(C(NCc2ncccc2)=O)sc(N=C2N3CCCCC2)c1C3=O

InChI

InChI=1S/C19H20N4O2S/c1-12-15-18(22-14-8-3-2-6-10-23(14)19(15)25)26-16(12)17(24)21-11-13-7-4-5-9-20-13/h4-5,7,9H,2-3,6,8,10-11H2,1H3,(H,21,24)

InChI Key

VEJGRJJTKSXBET-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14847117

C19H20N4O2S (E213-0377) in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Purinergic Library (3321 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • Receptor's ligands
  • PPI modulators
Therapeutical areas:
  • Nervous system
  • Cardiovascular
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • Proteases
  • GPCR
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C19H20N4O2S (E213-0377) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C19H20N4O2S (E213-0377)?
Check Price and Availability of C19H20N4O2S (E213-0377), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C19H20N4O2S (E213-0377) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C19H20N4O2S (E213-0377)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C19H20N4O2S (E213-0377)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C19H20N4O2S (E213-0377) available by request